Skip to main content

Panel Discussion - Abnormal Products of Conception and Mesenchymal Tumors



Original release date:
 April 29, 2020
Access to this course expires on:  November 6, 2022 at 11:59 PM Pacific Time
CME 1

Faculty:
Charles Matthew Quick, MD, Carlos Parra-Herran, MD, Vinita Parkash, MBBS, MPH & Joseph T. Rabban, MD, MPH

Learning Objectives:
  • Apply contemporary morphologic, immunohistochemical and molecular diagnostic criteria to classify uterine mesenchymal tumors other than smooth muscle tumors.
  • Distinguish morphologic variants of these tumors that may mimic each other or mimic uterine smooth muscle tumors.
  • Recognize tumors for which targeted therapy exists and use appropriate biomarkers to establish the diagnoses, such as for inflammatory myofibroblastic tumor and perivascular epithelioid cell tumor.